Quantitative Metabolomics Identifies Prognostic Biomarkers Associated with NSCLC after chemoradiotherapy

Puntos clave

• This research aims to identify reliable prognostic biomarkers associated with non-small cell lung cancer after chemoradiotherapy.
• Conducted quantitative metabolomics analysis on NSCLC samples post-chemoradiotherapy.
• Evaluated individual variability and its influence on treatment outcomes.
• Identified specific biomarkers that correlate with treatment response in NSCLC.
• Demonstrated the potential for these biomarkers to enhance precision therapy approaches.